LabCompass

Alan Breier

Medicine · Indiana University

OpenAlex
Schizophrenia research and treatmentFunctional Brain Connectivity StudiesBipolar Disorder and TreatmentTreatment of Major DepressionMental Health and Psychiatry

Publications

398

Citations

22,598

Est. group size

—

Recurring co-author estimate

Active years

45

Publishing since 1981

Research summary
AI-generated

Alan Breier researches schizophrenia and related psychotic disorders, focusing on both new drug treatments and brain-imaging studies of psychosis. His work includes clinical trials of novel medications (such as xanomeline-trospium, a muscarinic receptor-targeting drug) and neuroimaging analyses that map brain structure and connectivity in people with early psychosis. He also contributes to methodology for designing and evaluating clinical trials in psychiatry.

Schizophrenia treatment and clinical trialsNovel medications for psychosisBrain imaging and connectivity in psychosisEarly psychosis and cognitionClinical trial methodology

Publication activity has been steady and recently rising, averaging about 8 papers per year over the last five years with the highest counts in 2024 and 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.0/year recently
2017: 10 publications172018: 7 publications182019: 5 publications192020: 11 publications202021: 6 publications212022: 9 publications222023: 8 publications232024: 11 publications242025: 12 publications122526
Recent publications
Publishes in
  • Biological Psychiatry×11
  • Schizophrenia Bulletin×11
  • Schizophrenia Research×6
  • Human Brain Mapping×5
  • bioRxiv (Cold Spring Harbor Laboratory)×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile